您当前所在位置:首页 > 关于我们 > 新品上市
序号 标题 次数 作者 发布时间
78661 HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 197 h 2024-12-19
78662 HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 144 h 2024-12-19
78663 cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS 146 kx 2024-12-19
78664 4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) 143 kx 2024-12-19
78665 cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 142 kx 2024-12-19
78666 perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) 148 kx 2024-12-19
78667 cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 120 kx 2024-12-19
78668 perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 107 kx 2024-12-19
78669 cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) 161 kx 2024-12-19
78670 cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 173 kx 2024-12-19
78671 MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 118 WYQ 2024-12-19
78672 cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 145 kx 2024-12-19
78673 mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) 121 WYQ 2024-12-19
78674 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate 120 wyh 2024-12-19
78675 MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) 123 WYQ 2024-12-19
78676 2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate 112 wyh 2024-12-19
78677 MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) 111 WYQ 2024-12-19
78678 N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB 146 kx 2024-12-19
78679 MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) 99 WYQ 2024-12-19
78680 MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 135 WYQ 2024-12-19
78681 叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB 115 kx 2024-12-19
78682 MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 136 WYQ 2024-12-19
78683 MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) 195 WYQ 2024-12-19
78684 HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 116 h 2024-12-19
78685 Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB 161 kx 2024-12-19
78686 MC-GGFG-DX8951(CAS:1600418-29-8) 344 WYQ 2024-12-19
78687 (HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 161 h 2024-12-19
78688 Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 173 h 2024-12-19
78689 (HO)2-PO-S-(CH2)m-COONHS 硫-(2,5-二氧代 - 吡咯烷-1-基氧基羰基)-1-基硫代磷酸 130 h 2024-12-19
78690 2529982-76-9,Azido-PEG4-Val-Ala-PAB,叠氮-四聚乙二醇-VAL-ALA-PAB 145 kx 2024-12-19
78691 Au_12_C11EG6 金团簇12-直链烷烃六聚乙二醇 183 h 2024-12-19
78692 cas:863971-17-9 ,MC-Val-Cit-PAB-MMAF,MC-VAL-CIT-PAB-MMAF游离态 115 kx 2024-12-19
78693 CF3-(CF2)5-C2-O-C11-Si(OMe)3 巯基-直链烷烃连接氟化硫醇和硅烷 142 h 2024-12-19
78694 cas:2353409-69-3 , Mal-PEG8-Val-Cit-PAB-MMAE,马来酰亚胺-八聚乙二醇-VAL-CIT-PAB-MMAE 137 kx 2024-12-19
78695 cas:2129164-91-4 , DBCO-PEG4-Val-Cit-PAB-MMAE,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-MMAE 178 kx 2024-12-19
78696 MAL-di-EG-Val-Cit-PAB-MMAF,由ADC连接桥(MAL-di-EG-Val-Cit-PAB)和有效的微管蛋白聚合阻断剂(MMAF, Monomethyl auristatin F)组成 145 WYQ 2024-12-19
78697 MAL-di-EG-Val-Cit-PAB-MMAE,CAS编号:2746391-62-6 156 WYQ 2024-12-19
78698 cas:644981-35-1 , Val-Cit-PAB-MMAE, ADC试剂 100 kx 2024-12-19
78699 cas:2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE,抗体药物偶联物(ADC) 184 kx 2024-12-19
78700 AcLys-PABC-VC-Aur0101(CAS:1438851-17-2) 134 WYQ 2024-12-19
78701 反式环辛烯-MMAE,TCO-MMAE, ADC试剂 176 kx 2024-12-19
78702 Hydrazone-doxorubicin,阿霉素-腙键偶联物 233 WYQ 2024-12-19
78703 SPP-DM1(CAS号:452072-20-7)C44H59ClN4O14S2 191 WYQ 2024-12-19
78704 氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮),Amino-PEG2-VG-N-Bis(PEG1-azide) 110 kx 2024-12-19
78705 DOTA-NHS ester,羟基琥珀酰亚胺-四氮杂环十二烷四乙酸(CAS号:170908-81-3) 136 WYQ 2024-12-19
库存查询